United States Biospecimen Contract Research Services Market Size, Share, and COVID-19 Impact Analysis, By Biospecimen Type (Oncological Studies and Non-Oncological Studies), By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, and Others) and United States Biospecimen Contract Research Services Market Insights, Industry Trend, Forecasts to 2035

United States Biospecimen Contract Research Services Market Insights Forecasts to 2035

• The USA Biospecimen Contract Research Services Market Size is Expected to Grow at a CAGR of around 6.3% from 2025 to 2035.
• The United States Biospecimen Contract Research Services Market Size is Expected to Hold a Significant Share by 2035.

According to a research report published by Spherical Insights & Consulting, the U.S. biospecimen contract research services market is expected to hold a significant share by 2035, growing at a CAGR of 6.3% from 2025 to 2035. The United States biospecimen contract research services market is growing due to increasing demand for personalized medicine, rising R&D investment by pharmaceutical and biotech companies, and a surge in clinical trials. Advancements in biobanking technology and regulatory support for precision diagnostics further drive growth, along with growing collaboration between research institutions and commercial biospecimen service providers.

Market Overview

The U.S. biospecimen contract research services market encompasses the procurement, processing, and distribution of biological samples for research purposes. This market is propelled by the increasing demand for personalized medicine, advancements in genomics, and the growing need for high-quality biospecimens in drug discovery and clinical trials. Key strengths include the availability of diverse and well-characterized biospecimen collections, robust infrastructure, and a skilled workforce. Opportunities lie in expanding applications of biospecimens in emerging therapeutic areas, such as immuno-oncology and regenerative medicine, as well as integrating advanced technologies like artificial intelligence and machine learning to enhance data analysis and sample processing. Government initiatives play a pivotal role in supporting the market's growth. Agencies like the National Institutes of Health (NIH) and the National Cancer Institute (NCI) provide funding and resources for biobanking and biospecimen research. Additionally, the Biomedical Advanced Research and Development Authority (BARDA) facilitates the development and procurement of medical countermeasures, including biospecimen-related research, to address public health emergencies and emerging threats.

Report Coverage

This research report categorizes the market for the United States biospecimen contract research services market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States biospecimen contract research services market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States biospecimen contract research services market.

Driving Factors

The increasing focus on personalized medicine and precision diagnostics fuels demand for high-quality, well-annotated biospecimens. Rising investments in pharmaceutical and biotechnology R&D, along with the surge in clinical trials, further support market growth. The expanding use of biospecimens in genomics, oncology, and rare disease research is also a major contributor. Technological advancements in biobanking, automation, and data integration enhance sample storage, retrieval, and analysis capabilities. Additionally, collaborative efforts between academic institutions, government agencies, and private organizations are fostering innovation. Regulatory support and funding from entities like the NIH and NCI strengthen infrastructure and standardization, making biospecimen research more reliable and scalable across the country.

Restraining Factors

The high operational costs, complex regulatory compliance, and data privacy concerns. Maintaining biospecimen quality requires advanced infrastructure, which can be financially burdensome for smaller firms. Additionally, a lack of standardization in sample handling and storage practices poses challenges to the consistency, reliability, and scalability of research outcomes.

Market Segmentation

The United States biospecimen contract research services market share is classified into biospecimen type and therapeutic area.

• The oncological studies segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States biospecimen contract research services market is segmented by biospecimen type into oncological studies and non-oncological studies. Among these, the oncological studies segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to rising cancer prevalence and increased oncology-focused clinical trials. High demand for tumor tissues, blood, and related biospecimens supports biomarker discovery and precision medicine.

• The oncological disorders segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States biospecimen contract research services market is segmented by therapeutic area into oncological disorders, neurological disorders, cardiovascular disorders, and others. Among these, the oncological disorders segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the high prevalence of cancer and extensive research funding. Oncology trials often require a diverse range of biospecimens, including FFPE tissues, plasma, and serum, to support biomarker discovery and personalized medicine initiatives.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States biospecimen contract research services market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Eurofins Microbiology Lancaster Laboratories
• NeoGenomics Laboratories, Inc.
• Axiom Real-Time Metrics
• BioStorage Technologies
• Precision for Medicine
• Discovery Life Sciences
• Cryo-Cell International
• Asterand Bioscience
• Biobridge Global
• Creative Biolabs
• Conversant Bio
• Cureline, Inc.
• BioOptions
• Biochain
• BioIVT
• Others

Recent Developments:

• In July 2023, Discovery Life Sciences launched advanced flow cytometry clinical trial services by integrating Cytek Aurora instruments with full-spectrum technology. This integration, combined with genomics, molecular pathology, and proteomics services in one facility, saved valuable time and ensured high-quality results, accelerating drug and diagnostic development for researchers.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the USA, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the U.S. biospecimen contract research services market based on the below-mentioned segments:

USA Biospecimen Contract Research Services Market, By Biospecimen Type

• Oncological Studies
• Non-Oncological Studies

USA Biospecimen Contract Research Services Market, By Therapeutic Area

• Oncological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Others